Patent granted to Carestream for multi-modal imaging

Image source: Carestream Molecular Imaging
Carestream Molecular Imaging, a division of Carestream Health, has been granted Patent No. 7,734,325 by the U.S. Patent and Trademark Office for the technology titled “apparatus and method for multi-modal imaging,” related to its in vivo multispectral FX small animal imaging system.

Using the imaging system, one or more immobilized small animals can be imaged in several imaging modes without moving the animal. A movable phosphor screen allows users to image the test animal using multiple modalities with a single imager: x-ray and radioisotopic with the screen—fluorescence and luminescence without—all without moving the test animal.

This technology enables the generation of a single image comprising images from up to four modalities, said the Woodbridge, Conn.-based Carestream Molecular Imaging.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.